[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @a_a_free A.A A.A posts on X about $gmab, $bmrn, $mdgl, $exel the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1598803530218971137/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +36% - X Months XXXXXXX +1,405% - X Year XXXXXXX +2,137% ### Mentions: XX [#](/creator/twitter::1598803530218971137/posts_active)  - X Week XX -XX% - X Month XX +123% - X Months XXX +430% - X Year XXX +593% ### Followers: XXX [#](/creator/twitter::1598803530218971137/followers)  - X Week XXX +3.50% - X Month XXX +23% - X Months XXX +595% - X Year XXX +103% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1598803530218971137/influencer_rank)  ### Social Influence [#](/creator/twitter::1598803530218971137/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [technology brands](/list/technology-brands) **Social topic influence** [$gmab](/topic/$gmab) #10, [$bmrn](/topic/$bmrn), [$mdgl](/topic/$mdgl), [$exel](/topic/$exel), [$nbix](/topic/$nbix), [$abvx](/topic/$abvx), [$rna](/topic/$rna), [$vrdn](/topic/$vrdn), [$bbot](/topic/$bbot), [$mrus](/topic/$mrus) **Top assets mentioned** [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Exelixis Inc (EXEL)](/topic/$exel) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Incyte Corporation (INCY)](/topic/$incy) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Insmed, Inc. (INSM)](/topic/$insm) [Tarsus Pharmaceuticals, Inc. Common Stock (TARS)](/topic/$tars) [AbbVie Inc (ABBV)](/topic/$abbv) [Synthetify (SNY)](/topic/$sny) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams) [Biogen Inc (BIIB)](/topic/$biib) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) ### Top Social Posts [#](/creator/twitter::1598803530218971137/posts) --- Top posts by engagements in the last XX hours "My new long position last week $BBOT. I really like what I am seeing here. Will be a good name for the next few years to come" [X Link](https://x.com/a_a_free/status/1968722346010636297) [@a_a_free](/creator/x/a_a_free) 2025-09-18T17:02Z XXX followers, XXX engagements "Woow 8B it's almost XX% of the $GMAB MC two months ago. It was never expected it from GMAB. Now let's mid-size pharma if they can do deals: ALNY REGN UCB JAZZ INCY EXEL" [X Link](https://x.com/a_a_free/status/1972562885005172997) [@a_a_free](/creator/x/a_a_free) 2025-09-29T07:23Z XXX followers, XXX engagements "@AaronRosenblum5 Agree with you. Might be volatility for GMAB but long term will be positive. Genmab believes that petosemtamab will be accretive to EBITDA with at least one-billion-dollar annual sales potential by 2029 with multi-billion-dollar annual revenue potential thereafter" [X Link](https://x.com/a_a_free/status/1972572122607444344) [@a_a_free](/creator/x/a_a_free) 2025-09-29T08:00Z XXX followers, XXX engagements "$MDGL $IONS $ALNY $ARGX $BBIO $EXEL $INCY $BMRN $ASND $INSM $NBIX Probably companies should stay standalone and grow as this really can be very good for the second in the next decade in terms of M&A like what we saw from $GMAB. $GMAB made two acquisitions in the last XX months for 10B" [X Link](https://x.com/a_a_free/status/1973505613767299403) [@a_a_free](/creator/x/a_a_free) 2025-10-01T21:49Z XXX followers, XXX engagements "is $ABBV will go to $TARS or just the stock is up due to money rotation to Biotech" [X Link](https://x.com/a_a_free/status/1974201768780443948) [@a_a_free](/creator/x/a_a_free) 2025-10-03T19:55Z XXX followers, XXX engagements "I believe that $SNY will not let $ABVX go to any another company. That's my two cents about ABVX especially after the recent flop by SNY in AD" [X Link](https://x.com/a_a_free/status/1974926389297221917) [@a_a_free](/creator/x/a_a_free) 2025-10-05T19:55Z XXX followers, 2685 engagements "Who is next $RVMD or $RNA or $VRDN or $ABVX" [X Link](https://x.com/a_a_free/status/1976289331141882016) [@a_a_free](/creator/x/a_a_free) 2025-10-09T14:11Z XXX followers, 1426 engagements "$BMRN $GMAB $BCRX $JAZZ: I like what they did this year so far. It should be the case for $NBIX $MDGL $EXEL .etc to follow with such deals. Thanks" [X Link](https://x.com/a_a_free/status/1978056053993480582) [@a_a_free](/creator/x/a_a_free) 2025-10-14T11:11Z XXX followers, XXX engagements "@jq1234t @PCM_bio @plainyogurt21 @masonat7 @SnupSnus @PersimmonTI I disagree here I am with this take:" [X Link](https://x.com/a_a_free/status/1978234497687511358) [@a_a_free](/creator/x/a_a_free) 2025-10-14T23:00Z XXX followers, XXX engagements "So far news of M&A from $BIIB I was expecting them to do something this year. I still believe that my bet for them either $VRDN or $STOK or may be licence deal with $BHVN" [X Link](https://x.com/a_a_free/status/1978444446720000215) [@a_a_free](/creator/x/a_a_free) 2025-10-15T12:54Z XXX followers, 1178 engagements "@Andre_AGTC @A_May_MD @grok @Andre_AGTC you missed his point he means that abvx and nktr have first- in class MOA and there is no me too" [X Link](https://x.com/a_a_free/status/1978609270183588115) [@a_a_free](/creator/x/a_a_free) 2025-10-15T23:49Z XXX followers, XXX engagements "@AB1001_disciple @eurofighta @ValueHunter7 @TOWiU2 Agree with you on this point. Hope market will see the same way. Their issue that in last Q despite those fears didn't reduced their guidance they should do it" [X Link](https://x.com/a_a_free/status/1979805783404806631) [@a_a_free](/creator/x/a_a_free) 2025-10-19T07:04Z XXX followers, XX engagements "@svarre001 Yeah but at this level is not bad idea to go long. I believe durability of XXX will be ok" [X Link](https://x.com/a_a_free/status/1979873288185880912) [@a_a_free](/creator/x/a_a_free) 2025-10-19T11:32Z XXX followers, XX engagements "2026 will be the year of DM1 and wet AMD. $OCUL vs $EYPT and $DYN vs $RNA(clearly why ). For the moment I am long only $RNA. $OCUL: I don't trust their management. Any opinion on OCUL vs EYPT" [X Link](https://x.com/a_a_free/status/1953052736355786940) [@a_a_free](/creator/x/a_a_free) 2025-08-06T11:17Z XXX followers, 1688 engagements "@ohadhammer @grok can you do a deep search about GMAB LLY and AZ in this indication and who is in advanced stage" [X Link](https://x.com/a_a_free/status/1979878622610731158) [@a_a_free](/creator/x/a_a_free) 2025-10-19T11:53Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@a_a_free A.A
A.A posts on X about $gmab, $bmrn, $mdgl, $exel the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX +36%
- X Months XXXXXXX +1,405%
- X Year XXXXXXX +2,137%
Mentions: XX #
- X Week XX -XX%
- X Month XX +123%
- X Months XXX +430%
- X Year XXX +593%
Followers: XXX #
- X Week XXX +3.50%
- X Month XXX +23%
- X Months XXX +595%
- X Year XXX +103%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks finance technology brands
Social topic influence $gmab #10, $bmrn, $mdgl, $exel, $nbix, $abvx, $rna, $vrdn, $bbot, $mrus
Top assets mentioned BioMarin Pharmaceutical, Inc. (BMRN) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Exelixis Inc (EXEL) Neurocrine Biosciences, Inc. (NBIX) Avidity Biosciences, Inc. Common Stock (RNA) Merus N.V. Common Shares (MRUS) Ionis Pharmaceuticals, Inc. Common Stock (IONS) BridgeBio Pharma, Inc. Common Stock (BBIO) Incyte Corporation (INCY) Alnylam Pharmaceuticals, Inc. (ALNY) Insmed, Inc. (INSM) Tarsus Pharmaceuticals, Inc. Common Stock (TARS) AbbVie Inc (ABBV) Synthetify (SNY) Revolution Medicines, Inc. Common Stock (RVMD) Jazz Pharmaceuticals, Inc. (JAZZ) NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Biogen Inc (BIIB) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Dyne Therapeutics, Inc. Common Stock (DYN)
Top Social Posts #
Top posts by engagements in the last XX hours
"My new long position last week $BBOT. I really like what I am seeing here. Will be a good name for the next few years to come"
X Link @a_a_free 2025-09-18T17:02Z XXX followers, XXX engagements
"Woow 8B it's almost XX% of the $GMAB MC two months ago. It was never expected it from GMAB. Now let's mid-size pharma if they can do deals: ALNY REGN UCB JAZZ INCY EXEL"
X Link @a_a_free 2025-09-29T07:23Z XXX followers, XXX engagements
"@AaronRosenblum5 Agree with you. Might be volatility for GMAB but long term will be positive. Genmab believes that petosemtamab will be accretive to EBITDA with at least one-billion-dollar annual sales potential by 2029 with multi-billion-dollar annual revenue potential thereafter"
X Link @a_a_free 2025-09-29T08:00Z XXX followers, XXX engagements
"$MDGL $IONS $ALNY $ARGX $BBIO $EXEL $INCY $BMRN $ASND $INSM $NBIX Probably companies should stay standalone and grow as this really can be very good for the second in the next decade in terms of M&A like what we saw from $GMAB. $GMAB made two acquisitions in the last XX months for 10B"
X Link @a_a_free 2025-10-01T21:49Z XXX followers, XXX engagements
"is $ABBV will go to $TARS or just the stock is up due to money rotation to Biotech"
X Link @a_a_free 2025-10-03T19:55Z XXX followers, XXX engagements
"I believe that $SNY will not let $ABVX go to any another company. That's my two cents about ABVX especially after the recent flop by SNY in AD"
X Link @a_a_free 2025-10-05T19:55Z XXX followers, 2685 engagements
"Who is next $RVMD or $RNA or $VRDN or $ABVX"
X Link @a_a_free 2025-10-09T14:11Z XXX followers, 1426 engagements
"$BMRN $GMAB $BCRX $JAZZ: I like what they did this year so far. It should be the case for $NBIX $MDGL $EXEL .etc to follow with such deals. Thanks"
X Link @a_a_free 2025-10-14T11:11Z XXX followers, XXX engagements
"@jq1234t @PCM_bio @plainyogurt21 @masonat7 @SnupSnus @PersimmonTI I disagree here I am with this take:"
X Link @a_a_free 2025-10-14T23:00Z XXX followers, XXX engagements
"So far news of M&A from $BIIB I was expecting them to do something this year. I still believe that my bet for them either $VRDN or $STOK or may be licence deal with $BHVN"
X Link @a_a_free 2025-10-15T12:54Z XXX followers, 1178 engagements
"@Andre_AGTC @A_May_MD @grok @Andre_AGTC you missed his point he means that abvx and nktr have first- in class MOA and there is no me too"
X Link @a_a_free 2025-10-15T23:49Z XXX followers, XXX engagements
"@AB1001_disciple @eurofighta @ValueHunter7 @TOWiU2 Agree with you on this point. Hope market will see the same way. Their issue that in last Q despite those fears didn't reduced their guidance they should do it"
X Link @a_a_free 2025-10-19T07:04Z XXX followers, XX engagements
"@svarre001 Yeah but at this level is not bad idea to go long. I believe durability of XXX will be ok"
X Link @a_a_free 2025-10-19T11:32Z XXX followers, XX engagements
"2026 will be the year of DM1 and wet AMD. $OCUL vs $EYPT and $DYN vs $RNA(clearly why ). For the moment I am long only $RNA. $OCUL: I don't trust their management. Any opinion on OCUL vs EYPT"
X Link @a_a_free 2025-08-06T11:17Z XXX followers, 1688 engagements
"@ohadhammer @grok can you do a deep search about GMAB LLY and AZ in this indication and who is in advanced stage"
X Link @a_a_free 2025-10-19T11:53Z XXX followers, XXX engagements